The pharmaceutical company Galenika was founded in 1945. After privatization in November 2017, it became part of the NC Group (www.gruponc.net.br), one of the largest pharmaceutical companies in Latin America. Galenika produces generic medicines, nutritional supplements, medicinal products and products for daily use. The strategy of the new owner is to develop Galenika as a modern and flexible company, focused on research and development, which is constantly improving its products to improve health and quality of life, to the satisfaction of users.
